UNSPSC 51292502: Itasetron

This classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula C16H20N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00S0D0OEKR, chemically known as 2-oxo-n-1alphah,5alphah-tropan-3alpha-yl-1-benzimidazolinecarboxamide but generally known as itasetron, which bears US NIH Compound Identifier 60761. European Medicines Agency schedules Itasetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08350MIG.

UNSPSC 51292502 Itasetron (Commodity) names a pharmaceutical product with minimal recent state and local procurement activity; the single recorded opportunity shows a significant tagging mismatch. Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, but Naloxone is an opioid antagonist and drug deactivation systems are harm-reduction equipment, not itasetron (a selective 5-HT3 receptor antagonist commonly used for chemotherapy-induced nausea). The procurement indicates no specific set-aside or disadvantaged-enterprise designation, requires E-Verify compliance and standard commercial insurance (workers' compensation, commercial general liability, professional liability), and includes a three-month probationary termination clause. Potential FEMA funding carries Clean Air Act and Federal Water Pollution Control Act compliance obligations and audit exposure.

The code shows no secondary issuing bodies or geographic spread beyond this single Seminole County opportunity. Quarterly deliveries go to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida, with vendor responsibility for all shipping and delivery costs. The IFB closed July 26, 2023 (a date now historical relative to the June 30, 2026 posting date noted in the source). The substantial discrepancy between the code name and the work actually solicited suggests either a cataloging error or a state and local coding practice that does not align with the UNSPSC pharmaceutical classification. Absent corroborating recent opportunities under this code, pursue only if your firm operates in pharmaceutical supply to Florida county health departments and can clarify the underlying product specification.